Analysts Set Abbott Laboratories (NYSE:ABT) PT at $120.70
Shares of Abbott Laboratories (NYSE:ABT – Get Free Report) have received a consensus rating of “Moderate Buy” from the eight brokerages that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1-year price objective among […]
More Stories
Invesco S&P SmallCap Quality ETF (BATS:XSHQ) Plans Dividend Increase – $0.15 Per Share
Invesco S&P SmallCap Quality ETF (BATS:XSHQ – Get Free Report) declared a dividend on Friday, September 20th, NASDAQ reports. Investors...
Invesco Russell 1000 Dynamic Multifactor ETF (OMFL) to Issue Dividend of $0.11 on September 27th
Invesco Russell 1000 Dynamic Multifactor ETF (BATS:OMFL – Get Free Report) announced a dividend on Friday, September 20th, NASDAQ reports....
Cambria Global Momentum ETF (BATS:GMOM) Raises Dividend to $0.36 Per Share
Cambria Global Momentum ETF (BATS:GMOM – Get Free Report) declared a dividend on Friday, September 20th, NASDAQ reports. Shareholders of...
Invesco Short Duration Bond ETF (ISDB) to Issue Dividend of $0.11 on September 27th
Invesco Short Duration Bond ETF (BATS:ISDB – Get Free Report) announced a dividend on Friday, September 20th, NASDAQ reports. Investors...
Sudan: UN chief alarmed at full-scale assault on El Fasher
The UN Secretary-General is gravely alarmed by reports of a full-scale assault on El Fasher by the Rapid Support Forces...
Lennar (NYSE:LEN) Issues Quarterly Earnings Results, Beats Estimates By $0.28 EPS
Lennar (NYSE:LEN – Get Free Report) posted its quarterly earnings results on Thursday. The construction company reported $3.90 earnings per...